BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Sanjivani Paranteral Ltd. Share Price

NSE
BSE

BSE : 531569

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

High

Price Summary

Previous Close ₹187.95
Day's Range ₹183.30 - ₹192.85
Open ₹190.10
52 Week Range ₹126.00 - ₹268.80
Volume 3,723
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 7.00
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 34.97
TTM EPS (₹) 5.52
P/E Ratio 35.17
Book Value(₹) 4.92
PAT Margin (%) 11.13
Face Value (₹) 10.00
ROCE(%) 29.18

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 181.81 700.99
Expenses N/A N/A
PBT 26.61 103.6
Operating profit 0.0 0.0
Net profit 21.94 81.02

Shareholding Pattern

Promoters (% Holding)

31.56%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

62.98%

FI/Banks/Insurance (% Holding)

0.48%

Government (% Holding)

0.00%

FII

0.00%

About Sanjivani Paranteral Ltd.

Founded 1994
Managing Director Ashwani Khemka

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,67,630.39 1,952.75 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 2,18,971.76 8,275.00 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,88,358.16 4,915.50 3,480.60 - 3,480.60
Apollo Hospitals Enterprise Ltd. 1,29,125.81 8,921.00 6,696.50 - 6,696.50
Cipla Ltd. 1,18,915.99 1,460.00 1,165.70 - 1,165.70
Zydus Lifesciences Ltd. 1,11,241.63 1,120.70 835.50 - 835.50
Lupin Ltd. 1,07,907.43 2,275.00 1,875.00 - 1,875.00
Max Healthcare Institute Ltd. 1,04,432.24 1,070.00 903.00 - 903.00
Mankind Pharma Ltd. 1,00,729.72 2,438.00 1,909.70 - 1,909.70
Laurus Labs Ltd. 1,00,227.92 1,866.00 810.05 - 810.05
no-content No Records Found

Latest News

May
16
2026
EQUITY Posted on May 16th 2026

Sanjivani Paranteral informs about audio recording of earnings call

Sanjivani Paranteral has informed that it enclosed the audio recording of the earnings call with analysts and investors held on 15th May 2026 on the Audited financial results of the Company for the fourth quarter and year ended March 31, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Aug
10
2026
EQUITY Posted on Aug 10th 2026

Artemis Medicare Services submits analyst meet intimation

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Artemis Medicare Services has informed about the proposed schedule of ‘Investor Conference’ in which the representatives of the Company will be participating on Thursday, August 13, 2026.
The above information is a part of company’s filings submitted to BSE.  
Read More
Aug
10
2026
EQUITY Posted on Aug 10th 2026

Global Longlife Hospital and Research informs about SAST

Global Longlife Hospital and Research has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhruv Sureshkumar Jani.
The above information is a part of company’s filings submitted to BSE.
Read More
Aug
10
2026
EQUITY Posted on Aug 10th 2026

Syschem India informs about clarification

Syschem India has informed that due to an inadvertent typographical error, “Q2 (Quarter-2)” has been mentioned at certain places in the Investor Presentation, whereas the same should have been mentioned as ‘Ql (Quarter-1)’, pertaining to the First Quarter of Financial Year 2026-27. Accordingly, wherever ‘Q2 (Quarter-2)’ appears in the said Investor Presentation, the same shall be read and understood as ‘Q1 (Quarter-1)’. Further clarified that the aforesaid error is purely typographical in nature and does not have any impact on the financial figures, operational information, financial results, or any other disclosures contained in the Investor Presentation. The Company regrets the inadvertent typographical error and is taking necessary steps to upload the corrected Investor Presentation on the Stock Exchange portal. 
The above information is a part of company’s filings submitted to BSE.
Read More
Aug
9
2026
COMPANY Posted on Aug 9th 2026

Par Drugs & Chem. - Quaterly Results

A fair growth of 20.10% in the revenue at Rs. 312.81 millions was reported in the June 2026 quarter as compared to Rs. 260.46 millions during year-ago period.A comparatively good net profit growth of 41.65% to Rs. 47.14 millions was reported for the quarter ended June 2026 compared to Rs. 33.28 millions of previous same quarter.Operating profit surged to 73.16 millions from the corresponding previous quarter of 53.98 millions.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 312.81 260.46 20.10 312.81 260.46 20.10 1036.56 1009.74 2.66
Other Income 9.35 18.37 -49.10 9.35 18.37 -49.10 40.01 21.50 86.09
PBIDT 73.16 53.98 35.53 73.16 53.98 35.53 211.31 216.51 -2.40
Interest 0.21 0.16 31.25 0.21 0.16 31.25 1.27 0.82 54.88
PBDT 72.95 53.82 35.54 72.95 53.82 35.54 210.04 215.69 -2.62
Depreciation 9.64 9.04 6.64 9.64 9.04 6.64 37.03 36.47 1.54
PBT 63.31 44.78 41.38 63.31 44.78 41.38 173.01 179.22 -3.47
TAX 16.17 11.50 40.61 16.17 11.50 40.61 41.93 45.65 -8.15
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -3.36 0.40 -940.00
PAT 47.14 33.28 41.65 47.14 33.28 41.65 131.08 133.57 -1.86
Equity 123.05 123.05 0.00 123.05 123.05 0.00 123.05 123.05 0.00
PBIDTM(%) 23.39 20.72 12.85 23.39 20.72 12.85 20.39 21.44 -4.93
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Sanjivani Paranteral Ltd. ?

The current share price of Sanjivani Paranteral Ltd. is ₹187.95 as of 2026-08-10.

The market capitalisation of Sanjivani Paranteral Ltd. is ₹237.33 as of 2026-08-07.

The 1-year return of Sanjivani Paranteral Ltd. is -33.35% as of 2025-08-08.

The P/E ratio of Sanjivani Paranteral Ltd. is 35.17 as of 2026-08-10.

The 52-week high and low of Sanjivani Paranteral Ltd. are ₹268.80 and ₹126.00, respectively, as of 2026-08-10.

The dividend yield of Sanjivani Paranteral Ltd. is 0.0% as of2026-08-07.

You can buy Sanjivani Paranteral Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Sanjivani Paranteral Ltd. is Ashwani Khemka.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore